Evidence map›Paper›PMID 35758186›Full record

ArticleHistopathology2022

Cutaneous metastases of internal malignancies: a single-institution experience.

Astrid I P Vernemmen, Xiaofei Li, Guido M J M Roemen, Ernst-Jan M Speel, Bela Kubat, Axel Zur Hausen, Véronique J L Winnepenninckx, Iryna V Samarska

Abstract read
In one paragraph

Article in Histopathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Diagnosis and Management of Cutaneous Metastases from Melanoma.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Astrid I P VernemmenDepartment of Pathology, GROW-School for Oncology & Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Xiaofei LiDepartment of Pathology, GROW-School for Oncology & Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Guido M J M RoemenDepartment of Pathology, GROW-School for Oncology & Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Ernst-Jan M SpeelDepartment of Pathology, GROW-School for Oncology & Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Bela KubatDepartment of Pathology, GROW-School for Oncology & Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Axel Zur HausenDepartment of Pathology, GROW-School for Oncology & Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Véronique J L WinnepenninckxDepartment of Pathology, GROW-School for Oncology & Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Iryna V SamarskaDepartment of Pathology, GROW-School for Oncology & Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0003-4092-0672

Funding

Maastricht University
6 · The paper itself

Abstract

aimsCutaneous metastases of internal malignancies occur in 1-10% of cancer patients. The diagnosis can sometimes be challenging, especially in cases with an unknown primary cancer. MATERIALS AND

methodsA retrospective case review was performed including all cases of skin metastases from primary internal malignancies diagnosed at the Department of Pathology at the Maastricht University Medical Centre+ from 2007 to 2021. The clinicopathological data were collected and immunohistochemical and molecular diagnostic tests were performed to confirm the primary origin of the metastases.

resultsWe identified 152 cases (71 female; 31 male patients) of cutaneous metastases of internal malignancies. 28 patients (20 women and 8 men) were diagnosed with multiple cutaneous metastases. Among the female patients, the most common primary tumour was breast cancer (50% of the cases), followed by lung (13.6%), gynaecological (7.3%), and gastrointestinal origin (7.3%). Among the male patients, the most common primary sites were gastrointestinal and lung origin (altogether, 50% of the cases). In 19 patients, the cutaneous metastasis was the first presentation of a clinically silent internal malignancy (18.6%), of which most (78.9%) represented metastatic lung carcinomas. Finally, metastasizing patterns were different across tumour types and gender.

conclusionBreast, lung, gastrointestinal, and gynaecologic cancers are the most common primary tumours demonstrating skin metastases. Infrequently, cutaneous metastases can be the first clinically visual manifestation of an underlying not yet diagnosed internal malignancy; therefore, occasional broad immunohistochemical profiling, molecular clonal analysis, and a continuous high level of awareness are necessary for a precise diagnosis of cutaneous metastases of internal malignancies.

Indexed as

Breast NeoplasmsLung NeoplasmsSkin NeoplasmsFemaleHumansMaleRetrospective Studiesbreastcoloncutaneous metastasisinternal malignancylungskin

Identifiers

PMID35758186
PMCPMC9544513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.